Abstract
The external envelope glycoprotein (gp 160) of HIV-1 is a candidate for vaccines against AIDS. Most of the surface of the molecule is shielded by carbohydrate and the structures and locations of these glycans may be important in defining the immunogenicity of the viral coat. Here we report a sensitive mapping strategy for profiling and analysing the N-glycosylation of gp160, based on chemical release of glycans, fluorescent labelling and HPLC analysis. This approach has been validated in terms of establishing the reproducibility of all steps in the analytical procedure and on overall reproducibility on a run-to-run and day-to-day basis. The validated analysis technique was used to monitor the consistency of N-glycosylation of one rgp 160 vaccine candidate produced in bovine hamster kidney (BHK) cell culture. It was demonstrated that the variation in the glycan profiles of 6 different lots was not statistically significant.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Goochee CF, Gramer MJ, Anderson DC, Bahr JB, Am Chem Soc 2181, 199–240 (1992).
Anderson DC, Goochee CF, Current Opinion in Biotechnology 5, 546–9 (1994).
Goochee CF, Gramer MJ, Anderson DC, Bahr JB, Rasmussen JR, Biotechnology 9, 1347–55 (1991).
Varki A, Glycobiology 3, 97–130 (1993).
Rudd PM, Dwek RA, Crit Rev Biochem Mol 32, 1–100 (1997).
Van Den Steen P, Rudd PM, Dwek RA, Opdenakker G, Crit RevBiochem Mol 33, 151–208 (1998).
Fenouillet E, Glückman JC, Jones IM, TIBS 19, 65–70 (1994).
Hansen EJ, Lund O, Tolstrup N, et al., Glycoconjugate J 15 115–30 (1998).
Woods RJ, Edge CJ, Dwek RA, Nature Structural Biology 1, 499–501 (1994).
Mizuochi T, Spellman MW, Larkin M, Solomon J, Basa LJ, Feizi T, Biochem J 254, 599–603 (1988).
Taverna M, Tran NT, Valentin C, Merry T, Kolbe H, Ferrier D, J Biotechnology 68, 37–48 (1999).
Patel T, Bruce J, Merry A, Bigge C, Wormald M, Jaques A, Parekh R, Biochemistry 32, 679–93 (1993).
Merry AH, Bruce J, Bigge C, Ionnides A, Biochem Soc Trans 20, 91 (1992).
Bigge JC, Patel TP, Bruce JA, Goulding PN, Charles SM, Parekh RB, Anal Biochem 230, 229–38 (1995).
Manuscript in preparation
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tran, N., Taverna, M., Merry, A. et al. A sensitive mapping strategy for monitoring the reproducibility of glycan processing in an HIV vaccine, RGP-160, expressed in a mammalian cell line. Glycoconj J 17, 401–406 (2000). https://doi.org/10.1023/A:1007160115293
Issue Date:
DOI: https://doi.org/10.1023/A:1007160115293